Related Experiment Videos
Serum Ca-125 concentrations in endometriosis.
L Fedele1, L Arcaini, P Vercellini
1Clinica Ostetrica e Ginecologica L. Mangiagalli, Università di Milano.
This study investigated whether a blood test for Ca-125 could help diagnose endometriosis. Researchers measured Ca-125 levels in 154 women who had surgery for infertility or pelvic pain. They found that women with advanced endometriosis (stages III and IV) had much higher Ca-125 levels than those without the condition. However, women with mild endometriosis (stages I and II) had levels similar to those without the disease. The test correctly identified all women without endometriosis but missed most cases of mild disease. Because of this, the test is not recommended as a first step for diagnosing endometriosis. However, when Ca-125 levels are high, it may suggest the need for surgery in patients with symptoms like infertility or painful periods.
Area of Science:
- Gynecological diagnostics
- Reproductive endocrinology
- Serum biomarker analysis
Background:
Endometriosis diagnosis often relies on clinical symptoms and imaging, but these methods lack precision. Serum Ca-125 has been proposed as a potential biomarker for endometriosis. Prior research has shown that Ca-125 levels can vary in gynecological conditions. However, the diagnostic utility of Ca-125 in endometriosis remains unclear. No prior work had resolved how Ca-125 levels correlate with disease severity. This gap motivated researchers to investigate whether Ca-125 could serve as a diagnostic aid. The study aimed to clarify whether elevated Ca-125 levels are specific to endometriosis. It also sought to determine if these levels differ across disease stages. The findings could refine clinical approaches to diagnosing endometriosis.
Purpose Of The Study:
The study aimed to evaluate the diagnostic potential of serum Ca-125 in endometriosis. Researchers focused on comparing Ca-125 levels in patients with different endometriosis stages. They also compared these levels to those in a control group. The goal was to determine if Ca-125 could help distinguish endometriosis from other conditions. The study sought to assess the sensitivity and specificity of Ca-125 as a diagnostic tool. Researchers hypothesized that higher Ca-125 levels might correlate with more severe disease. They also wanted to explore whether Ca-125 could guide surgical decisions. The study's design allowed for a direct comparison between diagnostic groups.
Main Methods:
The study included 154 patients undergoing laparoscopy or laparotomy for infertility or pelvic pain. Pelvic endometriosis was confirmed in 102 patients, while 52 served as controls. Serum Ca-125 levels were measured in all participants. Patients were categorized based on endometriosis stage (I–IV). Mean Ca-125 concentrations were compared between groups using statistical analysis. The study used a control group with no endometriosis for comparison. Researchers evaluated sensitivity and specificity of Ca-125 as a diagnostic marker. The data were analyzed to determine if Ca-125 levels correlated with disease severity.
Main Results:
Patients with stages III and IV endometriosis had significantly higher Ca-125 levels than controls (P < 0.001). Ca-125 levels in stages I and II were not significantly different from controls. The overall sensitivity of Ca-125 for endometriosis was low at 14.7%. Specificity was high at 100%, indicating no false positives in the control group. Elevated Ca-125 levels were strongly associated with advanced disease stages. The test correctly identified all controls as negative for endometriosis. However, it failed to detect most cases of mild endometriosis. These findings suggest Ca-125 is not useful as an initial screening test.
Conclusions:
The authors concluded that serum Ca-125 has limited utility as a primary diagnostic test for endometriosis. Its low sensitivity means it misses most cases of the condition. However, the test's high specificity suggests it could be useful in certain clinical scenarios. Elevated Ca-125 levels may indicate the need for surgical exploration in patients with infertility or dysmenorrhea. The test is not recommended for routine screening due to its poor sensitivity. The findings suggest that Ca-125 should be used cautiously in clinical decision-making. The authors propose that Ca-125 could be a helpful indicator in advanced cases. These conclusions are based strictly on the observed data and statistical analysis.
Frequently Asked Questions
The study found that Ca-125 levels are significantly higher in advanced endometriosis (stages III and IV) compared to controls, but not in mild cases.
Researchers measured Ca-125 in 154 patients undergoing laparoscopy or laparotomy, comparing levels across endometriosis stages and a control group.
The test has low sensitivity (14.7%), meaning it fails to detect most endometriosis cases, even though it has high specificity.
Elevated Ca-125 levels may indicate the need for early surgical exploration in patients with infertility or dysmenorrhea.
The study reported a 100% specificity, meaning no false positives were observed in the control group.
The authors suggest Ca-125 may be useful in advanced cases but not as a routine initial diagnostic test due to its low sensitivity.